Crossmark

Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials

Published Online: 2019-05-09

Authors

Mahmoudpour, Seyed Hamidreza

Jankowski, Marius

Valerio, Luca

Becker, Christian

Espinola-Klein, Christine

Konstantinides, Stavros

Quitzau, Kurt

Barco, Stefano
Funding

Funding for this research was provided by:

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1003)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1503)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1503)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1003)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1503)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1003)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1503)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1003)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1003)

Bundesministerium f&#x00FC;r Bildung und Forschung (01EO1503)
License Information

Text and Data Mining valid from 2019-05-09

Version of Record valid from 2019-05-09
More Information

Article History

Received: 8 March 2019

Accepted: 26 April 2019

First Online: 9 May 2019

Competing Interests

: The authors declare no competing interests.

Document is current